Alejandro Nino-Murcia

Alejandro Nino-Murcia

Auto-generated profile, based on publicly available information

Alejandro Nino-Murcia

Department of Transplantation Surgery, Colombiana de Trasplantes, Bogotá, Colombia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2022 in Research and Reports in Urology
Verified
Journal Article
Open access
PDF file
LNLaura Nino-Torres
Laura Nino-Torres
AGAndrea Garcia-Lopez
Andrea Garcia-Lopez
NPNasly Patino-Jaramillo
Nasly Patino-Jaramillo
FGFernando Giron-Luque
Fernando Giron-Luque
ANAlejandro Nino-Murcia
Alejandro Nino-Murcia
Background and Purpose: Kidney transplantation (KT) is the best therapy for chronic kidney disease (CKD). Major urologic complications (MUCs) are the second etiology associated to morbidity and graft loss following KT, after rejection episodes. The objective of this study was to estimate the incidence, risk factors and impact on graft survival associated to urological complications in KT patients. Patients and Methods: A retrospective cohort based on electronic patient files of kidney transplant recipients from Colombiana de Trasplantes was created for the period August 2008 to September 2019. Initiation of follow-up was defined as the date of transplantation up to 3 years post-transplantation. Incidence of ureteral stenosis, ureteral obstruction, and ureteral leak was measured. A logistic regression multivariate model was adjusted to determine the associated factors to MUCs (yes/no). Patient and graft survival time were analyzed using a Kaplan-Meier method. Results: A total of 1584 KT patients were included in the cohort. MUCs were present in 195 (12.6%) KT patients. We found that dialysis duration (OR: 1.004; p = 0.02) remained significant for the incidence of MUCs in KT patients of deceased donors. Probability of graft and patient survival at 3 years of follow-up was 90.5% and 85.5%, respectively. No significant difference was found on graft and patient survival in KT patients with or without MUCs. Conclusion: MUCs are frequent complications for KT. We did not observe significant differences in graft or patient survival according to the presence of MUCs. The identification of MUCs and risk factors may guide transplant teams for future surgical and clinical decisions.

26 February 2024 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
LNLaura Nino-Torres
Laura Nino-Torres
JPJessica Pinto-Ramirez
Jessica Pinto-Ramirez
FGFernando Giron-Luque
Fernando Giron-Luque
ANAlejandro Nino-Murcia
Alejandro Nino-Murcia
Background: In chronic kidney disease (CKD), there are historical inequities in multiple stages of the pathway for organ transplantation. Women have been recognized as disadvantaged within this process even after several efforts. Therefore, we aimed to analyze the prevalence and incidence of CKD by gender and their access to Kidney replacement therapy (KRT) in Colombia. Methods: A cross-sectional study based on secondary analysis of national information on CKD, hypertension, diabetes, waiting list, deceased, and living donor transplantation between 2015 and 2020. Results: In Colombia, 4.934.914 patients were diagnosed with hypertension, diabetes, or CKD. 60,64% were female, with a mean age of 63.84 years (SD 14,36). Crude incidence for hypertension (10.85 vs. 7.21 /1000 inhabitants), diabetes mellitus (3.77 vs. 2.98 /1000 inhabitants), and CKD (4 vs. 2 /1000 inhabitants) was higher for females. Crude incidence for KRT was 86.45 cases /100.0000 inhabitants. In 2020, 2978 patients were on the waiting list, 44% female. There were 251 deaths on the waiting list, 38% female. This year, 517 kidney transplants were performed, and only 40% were female. Conclusion: In Colombia, there are proportionally more females with CKD and precursor comorbidities. Nevertheless, there are fewer females on the waiting list and transplanted annually.

1 September 2021 in Transplantation Proceedings
Verified
Journal Article
Closed access
LNLaura Nino-Torres
Laura Nino-Torres
AGAndrea Garcia-Lopez
Andrea Garcia-Lopez
FGFernando Giron-Luque
Fernando Giron-Luque
ANAlejandro Nino-Murcia
Alejandro Nino-Murcia

29 July 2020 in Revista Colombiana de Cirugía
Verified
Journal Article
Open access
PDF file
RYRamón Abel Castaño Yepes
Ramón Abel Castaño Yepes
GNGloria Arias Nieto
Gloria Arias Nieto
OGOoswaldo A. Borráez Gaona
Ooswaldo A. Borráez Gaona
AMAlejandro Nino Murcia Alejandro Nino Murcia
Alejandro Nino Murcia Alejandro Nino Murcia
LPLiliana Támara Patiño Liliana Támara Patiño
Liliana Támara Patiño Liliana Támara Patiño
JMJulieta Moreno Molina
Julieta Moreno Molina
CONTEXTO La profesión médica, fiel a su compromiso de buscar el beneficio de los pacientes y lograr los mejores resultados posibles en el proceso de atención, respetando sus derechos y voluntad, se enfrenta al reto de la pandemia de COVID-19 y la consecuente situación de emergencia sanitaria, la cual conlleva un estado de excepcionalidad que modifica de manera fundamental algunos elementos tradicionales de la práctica médica.

25 August 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LNLaura Nino-Torres
Laura Nino-Torres
AGAndrea García-Lopez
Andrea García-Lopez
NPNasly Patino-Jaramillo
Nasly Patino-Jaramillo
FGFernando Giron-Luque
Fernando Giron-Luque
ANAlejandro Nino-Murcia
Alejandro Nino-Murcia
A complex relationship between donor and recipient characteristics influences kidney transplant (KT) success. A tool developed by Bae S. et al. (Survival Benefit Estimator, SBE) helps estimate post-KT survival. We aim to evaluate the predictive performance of the SBE tool in terms of 5-year patient survival after a kidney transplant. A retrospective cohort study of all deceased-donor KT recipients between January 2009 to December 2021. A descriptive analysis of clinical and sociodemographic characteristics was performed. The SBE online tool was used to calculate the predicted patient survival (PPS) and the survival benefit at five years post-KT. Comparisons between predictive vs. actual patient survival were made using quintile subgroups. Three Cox regression models were built using PPS, EPTS, and KDPI. A total of 1145 recipients were evaluated. Mortality occurred in 157 patients. Patient survival was 86.2%. Predictive survival for patients if they remained on the waiting list was 70.6%. The PPS was 89.3%, which results in a survival benefit (SB) of 18.7% for our population. Actual survival rates were lower than the predicted ones across all the quintiles. In unadjusted analysis, PPS was a significant protective factor for mortality (HR 0.66), whereas EPTS (HR 8.9) and KDPI (HR 3.25) scores were significant risk factors. The discrimination of KDPI, PPS, and EPTS scores models were 0.59, 0.65, and 0.66, respectively. SBE score overestimated actual survival rates in our sample. The discrimination power of the score was moderate, although the utility of this tool may be limited in this specific population.